The expression of PD-1 on NK cells interacting with PD-L1 on cancer cells can decrease the responses of NK cells, whereas blocking PD-1 and PD-L1 can increase NK cells in vivo and trigger strong NK cell responses and cytotoxicity in mouse tumor models (177, 178). Here, PDCD1 is linked to cancer.